Pembrolizumab Plus Vorinostat a Potential Combo for Lung Cancer - DocWire News

Pembrolizumab Plus Vorinostat a Potential Combo for Lung Cancer  DocWire News

A phase I/Ib study published in Clinical Cancer Research found that treatment with the immune checkpoint inhibitor (ICI) pembrolizumab plus the histone.



Comments

Popular posts from this blog